Last Update Time:
04-Mar-2025 16:00:00
ISIN:
INE03QK01018
Sector:
Healthcare
Symbol:
SUVENPHAR
Suven Pharmaceuticals Limited
₹1,150.80
₹10.70
(0.94%)
▲
Prev. Close
₹1,140.10
Open
₹1,140.00
Close
₹1,163.60
Range
₹1,093.26 - ₹1,208.34
High
₹1,177.00
Low
₹1,105.00
Ind. Close
₹0.00
VWAP
₹1,154.19
The current stock price of Suven Pharmaceuticals Limited is ₹1,150.80, with a target price range between ₹1,093.26 and ₹1,208.34. The stock has experienced a price change of ₹10.70 (0.94%), reflecting recent market volatility.
Today's opening price was ₹1,140.00, while the previous close stood at ₹1,140.10.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Suven Pharmaceuticals Limited Price Chart
Suven Pharmaceuticals Limited Pre Open Market Overview: 04-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1140
- Previous Close Price: 1140.1
- Change: -0.10%
- Total Traded Volume: 100
- Total Buy Quantity: 2,671
- Total Sell Quantity: 7,077
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 1,128.00 | 100.00 | 0.00 |
| 1,129.05 | 100.00 | 0.00 |
| 1,130.00 | 25.00 | 0.00 |
| 1,135.00 | 1.00 | 0.00 |
| 1,135.30 | 5.00 | 0.00 |
| 1,140.00 | 0.00 | 212.00 |
| 1,140.10 | 0.00 | 464.00 |
| 1,145.90 | 0.00 | 1.00 |
| 1,150.00 | 0.00 | 25.00 |
| 1,158.00 | 0.00 | 280.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 2671
Total Sell Quantity: 7077
Shareholding Patterns of Suven Pharmaceuticals Limited
Key Trade Statistics of Suven Pharmaceuticals Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 3.65 |
| Traded Value (₹ Cr.) | 42.07 |
| Total Market Cap (₹ Cr.) | 29,295.34 |
| Free Float Market Cap (₹ Cr.) | 14,577.94 |
| Impact cost | 0.08 |
| Quantity Traded | 364,500.00 |
| Deliverable Quantity | 107,801.00 |
| % of Quantity to Traded | 29.58 |
| Security VaR | 14.4 |
| Index VaR | N/A |
| VaR Margin | 14.4 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 17.9 |
| Face Value | 1 |
Key Price Statistics of Suven Pharmaceuticals Limited
The 52-week high for Suven Pharmaceuticals Limited was ₹1,360.00, recorded on 02-Dec-2024. On the other hand, the 52-week low stands at ₹598.00, with the lowest value recorded on 03-Jun-2024.
The upper band for trading is ₹1,368.10, and the lower band is ₹912.10. The price band is 20%.
The stock's daily volatility stands at 2.24, while the annualized volatility is 42.80. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (02-Dec-2024) | 1,360.00 |
| 52 Week Low (03-Jun-2024) | 598.00 |
| Upper Band | 1,368.10 |
| Lower Band | 912.10 |
| Price Band (%) | 20 |
| Daily Volatility | 2.24 |
| Annualised Volatility | 42.80 |
| Tick Size | 0.05 |
Key Securities Statistics of Suven Pharmaceuticals Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 09-Mar-2020 |
| Adjusted P/E | 103.88 |
| Symbol P/E | 103.88 |
| Index | NIFTY 500 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Suven Pharmaceuticals Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Suven Pharmaceuticals Limited
| Subject | Date |
|---|---|
| Credit Rating | 28-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 24-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 20-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 18-Feb-2025 |
| Copy of Newspaper Publication | 13-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 12-Feb-2025 |
| Integrated Filing- Financial | 12-Feb-2025 |
| Investor Presentation | 12-Feb-2025 |
Corporate Actions of Suven Pharmaceuticals Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 1 | Annual General Meeting | 06-Aug-2024 |
| 1 | Annual General Meeting | 12-Dec-2023 |
| 1 | Interim Dividend - Re 1 Per Share/Special Dividend- Rs 5 Per Share | 09-Sep-2022 |
| 1 | Annual General Meeting | 11-Aug-2022 |
| 1 | Interim Dividend - Re 1 Per Share/Special Dividend - Re 1 Per Share | 13-May-2022 |
| 1 | Interim Dividend - Re 1 Per Share/ Special Dividend - Rs 2 Per Share | 15-Feb-2022 |
| 1 | Annual General Meeting/Dividend - Re 1 Per Share | 13-Aug-2021 |
| 1 | Interim Dividend - Re 1 Per Share | 17-Feb-2021 |
| 1 | Bonus 1:1 | 25-Sep-2020 |
Board Meetings of Suven Pharmaceuticals Limited
Financial Results of Suven Pharmaceuticals Limited
Company Directory of Suven Pharmaceuticals Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.suvenpharm.com | Registered Office | # 8-2-334, 3rd FLOOR, SDE SERENE CHAMBERS AVENUE 7, ROAD NO 5 BANJARA HILLS HYDERABAD | HYDERABAD |
Insider Trading of Suven Pharmaceuticals Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED | 63130836285 | Sell |
| 7(2) | PADMAJA J.A.S | 14049630 | Sell |
| 7(2) | PADMAJA J.A.S | 3375726 | Sell |
| 7(2) | PADMAJA J.A.S | 3203198 | Buy |
| 7(2) | PADMAJA J.A.S | 1720386 | Buy |
| 7(2) | PADMAJA J.A.S | 3514022 | Buy |
| 7(2) | PADMAJA J.A.S | 3428711 | Buy |
| 7(2) | PADMA KUMAR R | 4703067 | Buy |
Annual Reports of Suven Pharmaceuticals Limited
Investor Complaints of Suven Pharmaceuticals Limited
Event Calendar of Suven Pharmaceuticals Limited
| Purpose | Details |
|---|---|
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2020 and other business matters 2) Suven Pharma Employee Stock Option Scheme 2020 under SEBI (Share Based Employee Benefits) Regulations, 2014 3) Increase in Authorised Capital and 4) Issue of Bonus Shares |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2020 and dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2021 and dividend |
| Financial results | Suven Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 08-Aug-2022 to consider financial statements for the period ended June 2022 |
| Dividend | Suven Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 02-Sep-2022 to consider Dividend |
| Financial results | Suven Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 08-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2023 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
| Financial Results | SUVENPHAR : 30-May-2024 : The Company has informed the Exchange that a Board meeting to be held on May 27, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2024, To consider and approve the financial results for the period ended March 31, 2024 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ending December 31, 2024 |
Share Transfers of Suven Pharmaceuticals Limited
Voting Results of Suven Pharmaceuticals Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 18-DEC-2024 | Postal Ballot | Approval of the appointment of Mr. Vivek Sharma (DIN: 08559495), as an Executive Chairman and Director of the Company |
| 18-DEC-2024 | Postal Ballot | Approval of the appointment of Mr. Vinod Padikkal (DIN: 07765484), as a Non-Executive and Non-Independent Director of the Company |
| 18-DEC-2024 | Postal Ballot | Approval of the appointment of Mr. Jai Shankar Krishnan (DIN: 01519264), as an Independent Director of the Company |
| 28-NOV-2024 | Court Convened Meeting | Approval for the Scheme of Amalgamation amongst Cohance Lifesciences Limited and Suven Pharmaceuticals Limited and their respective Shareholders |
| 28-NOV-2024 | Court Convened Meeting | Approval for the Scheme of Amalgamation amongst Cohance Lifesciences Limited and Suven Pharmaceuticals Limited and their respective Shareholders |
| 09-AUG-2024 | AGM | Adoption of financial statements |
| 09-AUG-2024 | AGM | Appointment of Statutory Auditors of the Company |
| 09-AUG-2024 | AGM | To Appoint Mr. Pankaj Patwari as a Director liable to retire by rotation |
| 13-FEB-2024 | Postal Ballot | Approval of Suven Pharmaceuticals Limited Employee Stock Option Plan 2023 |
| 13-FEB-2024 | Postal Ballot | Approval of ￢ﾀﾜSuven Pharmaceuticals Limited Employee Stock Option Plan 2023￢ﾀﾝ (the ￢ﾀﾜPlan￢ﾀﾝ or ￢ﾀﾜESOP 2023￢ﾀﾝ) to the employees of Associate Company(ies) and its Subsidiary Company (ies) [present and future]: |
| 15-DEC-2023 | AGM | Adoption of financial statements |
| 15-DEC-2023 | AGM | Appointment of Ms. Shweta Jalan (DIN: 00291675) as Director of the Company |
| 15-DEC-2023 | AGM | Appointment of Mr. Pankaj Patwari (DIN: 08206620) as Director of the Company |
| 15-DEC-2023 | AGM | Appointment of Mr. Pravin Rao Udhyavara Bhadya (DIN: 06782450) as an Independent Director of the Company |
| 15-DEC-2023 | AGM | Appointment of Mr. Kumarapuram Gopalakrishnan Ananthakrishnan (DIN: 00019325) as an Independent Director of the Company |
| 15-DEC-2023 | AGM | Appointment of Mr. Vinod Rao (DIN: 01788921) as an Independent Director of the Company |
| 15-DEC-2023 | AGM | Appointment of Ms. Matangi Gowrishankar (DIN: 01518137) as an Independent Director of the Company |
| 15-DEC-2023 | AGM | Appointment of Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju (DIN: 07267366) as Managing Director of the Company |
| 15-DEC-2023 | AGM | Appointment of Mr. Vaidheesh Annaswamy (DIN: 01444303) as an Executive Chairman of the Company |
| 15-DEC-2023 | AGM | To approve and ratify the Interim Dividend on Equity Shares @ INR 6.00 per equity share for the financial year 2022-23 |
FAQs on Suven Pharmaceuticals Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.